A review of the pharmacologic treatment of migraine in children;Revisión del tratamiento farmacológico de la migraña en niños

Revista de Neurologia

Volumn 37, Issue 3, 2003, Pages 253-259

  Vasconcellos, Elza ^a  

^a MIAMI CHILDREN'S HOSPITAL   (United States)

Author keywords

Adolescent; Children; Migraine; Treatment

Indexed keywords

ALMOTRIPTAN; AMITRIPTYLINE; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; CLONIDINE; CYPROHEPTADINE; DIHYDROERGOTAMINE; ELETRIPTAN; ERGOTAMINE DERIVATIVE; FLUNARIZINE; FROVATRIPTAN; NARATRIPTAN; NIMODIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PAPAVERINE; PIZOTIFEN; PLACEBO; PROCHLORPERAZINE; PROPRANOLOL; RIZATRIPTAN; SUMATRIPTAN; TIMOLOL; TRAZODONE; TRYPTOPHAN; ZOLMITRIPTAN;

CHILD; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; HEADACHE; HUMAN; MIGRAINE; NAUSEA; PHOTOPHOBIA; PROPHYLAXIS; SIDE EFFECT; VOMITING;

EID: 0141989926     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3703.2003164     Document Type: Conference Paper

References (83)

1. García L, Papazian O. Headache: Home remedy therapy. Int Pediatr 1987; 2: 129-33.
2. Shinnar S, D'Souza BJ. The diagnosis and management of headache in children. Pediatr Clin North Am 1981; 29: 79-94.
3. Bille B. Migraine in school children. Acta Paediatr Scand 1962; 519 (Suppl): 1-151.
4. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headaches disorder, cranial neuralgias and facial pain. Cephalalgia 1988; 8 (Suppl): 1-96.
5. Abu-Aref I, Russell G. Prevalence of headache and migraine in school children. Br Med J 1994; 309: 795-6.
6. Split W, Neumann W. Epidemiology of migraine among students from randomly selected secondary schools in Lodz. Headache 1999; 39: 494-501.
7. Stewart WF, Linet MS, Celentano DD, Van Natta M, Ziegler D. Age and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol 1991; 134: 1111-20.
8. Hämäläinen ML, Hoppu K, Santavuori P. Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently than adults? Neurology 1997; 48: 1100-3.
9. Korsgard AG. The tolerability, safety and efficacy of oral sumatriptan 50 and 100 mg for the acute treatment of migraine in adolescent. Cephalalgia 1995: 15 (Suppl 16): 99 [abstract].
10. Winner P, Lewis D, Visser WH, Jiang K, Ahrens S, Evans JK. Rizatriptan Adolescent Study Group. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study. Headache 2002; 42: 49-55.
11. Winner P, Wasiewski W, Gladstein J, Linder S. Multicenter prospective evaluation of proposed pediatric migraine revisions to the HIS criteria. Headache 1997; 37: 545-8.
12. Olness KN, MacDonald JT. Recurrent headaches in children: diagnosis and treatment. Pediatr Rev 1987; 8: 307-11.
13. Hermann C, Kim M, Blanchard EB. Behavioral and prophylactic pharmacological intervention studies of pediatric migraine: an exploratory meta-analysis. Pain 1995; 60: 239-56.
14. Halpern MT, Lipton RB, Cady RK, Kwong WJ, Marlo KO, Batenhorst AS. Costs and outcomes of early versus delayed migraine treatment with sumatriptan. Headache 2002; 42: 984-99.
15. Symon DN. Twelve cases of analgesic headache. Arch Dis Child 1998; 78: 555-6.
16. Vasconcellos E, Pina-Garza JE, Millán EJ, Warner JS. Analgesic rebound headache in children and adolescents. J Child Neurol 1998; 13: 443-7.
17. Mathew NT, Kurman R, Pérez F. Drug induced refractory headaches-clinical features and management. Headache 1990; 30: 634-8.
18. Kappler JA. Rebound headache: definition, symptomatology, treatment, and prevention. Headache Quarterly 1992; 3: 398-402.
19. Lippman CW. Characteristic headache resulting from prolonged use of ergot derivates. J Nerv Ment Dis 1955; 3: 270-3.
20. Saper JR, Jones JM. Ergotamine dependency. Features and possible mecahnisms. Clin Neuropharmacol 1986; 9: 244-56.
21. Igarashi M, May WN, Golden GS. Pharmacologic treatment of childhood migraine. J Pediatr 1992; 120: 653-7.
22. Hockaday JM, Barlow CF. Headache in children. In Olesen J, Tfelt-Hansen P, Welch KMA, eds. The headaches. New York: Raven Press; 1993. p. 795-808.
23. Lanzi G, Balottin U, Zambrino CA. Guidelines and recommendations for the treatment of migraine in paediatric and adolescents patients. Funct Neurol 1996; 11: 269-75.
24. Hämäläinen ML, Hoppu K, Valkeila E, Santavuori P. Ibuprofen or acetaminophen for the acute treatment of migraine in children. Neurology 1997; 48: 103-7.
25. Lewis DW, Kellstein D, Dahl G, Burke B, Frank LM, Northam RS, et al. Children's ibuprofen suspension for the acute treatment of pediatric migraine. Headache 2002; 42: 780-6.
26. Soriani S, Battistella PA, Cernetti R. Acetaminophen versus nimesulide for the treatment of juvenile migraine [abstract]. Cephalalgia 1997; 17: 297.
27. Silberstein SD. The pharmacology of ergotamine and dihydroergotamine. Headache 1997; 37: S15-25.
28. Congdon PJ, Forsyth WI. Migraine in childhood: a study of 300 children. Dev Med Child Neurol 1979; 21: 209-16.
29. Hämäläinen ML, Hoppu K, Santavuori PR. Oral dihydroergotamine for therapy-resistant migraine attacks in children. Pediatr Neurol 1997; 16: 114-7.
30. Linder SL. Treatment of childhood headache with dihydroergotamine mesylate. Headache 1994; 34: 578-80.
31. Diamond S. A fresh look at migraine therapy. New treatments promises improved management. Postgrad Med 2001; 109: 49-54, 57-60.
32. Rothner AD, Winner P, Nett R, Asgharnejad M, Laurenza A, Austin R, et al. One-year tolerability and efficacy of sumatriptan nasal spray in adolescents with migraine: results of a multicenter, open-label study. Clin Ther 2000; 22: 1533-46.
33. Winner P, Rothner AD, Saper J, Nett R, Asgharnejad M, Laurenza A, et al. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics 2000; 106: 989-97.
34. Ueberall MA, Wenzel D. Intranasal sumatriptan for the acute treatment of migraine in children. Neurology 1999; 52: 1507-10.
35. Hershey AD, Powers SW, LeCates S, Bentti AL. Effectiveness of nasal sumatriptan in 5-to 12-year-old children. Headache 2001; 41: 693-7.
36. Linder SL. Subcutaneous sumatriptan in the clinical setting: the first 50 consecutive patients with acute migraine in pediatric neurology office practice. Headache 1996; 36: 419-22.
37. McDonald JT. Treatment of juvenile migraine with subcutaneous sumatriptan. Headache 1994; 34: 581-2.
38. Wasiewski W, Winner PK. Zolmitriptan is well tolerated in adolescents. Ann Neurol 1999; 46: 541 [abstract].
39. Linder SL, Dowson AJ. Zolmitriptan provides effective migraine relief in adolescents. Int J Clin Pract 2000; 54: 466-9.
40. Kabbouche MA, Vockell AL, Lecates SL, Powers SW, Hershey AD. Tolerability and effectiveness of prochlorperazine for intractable migraine in children. Pediatrics 2001; 107: 62.
41. Hershey AD, Powers SW, Bentti AL, DeGrauw TJ. Characterization and response pattern on children presenting to a multi-disciplinary pediatric headache center using detailed computer database. Headache 1999; 39: 358.
42. Silberstein SD, for the US Headache Consortium. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review). Neurology 2000; 55: 754-62.
43. Serdaroglu G, Erhan E, Tekgul H, Oksel F, Erermis S, Uyar M, et al. Sodium valproate prophylaxis in childhood migraine. Headache 2002; 42: 819-22.
44. Caruso JM, Brown WD, Exil G, Hascon GG. The efficacy of divalproex sodium in the prophylactic treatment of children with migraine. Headache 2000; 40: 672-6.
45. Palkanis A, Greenberg G, Drake ME Jr, Paolichi J. Pediatric migraine prophylaxis with divalproex. J Child Neurol 2001; 16: 731-4.
46. Krusz JC, Scott V. Topiramate in the treatment of chronic migraine and other headaches. Headache 2000; 39: 363.
47. Shuiab A, Ahmed F, Muratoglu M, Kochanski P. Topiramate in migraine prophylaxis: a pilot study. Cephalalgia 1999; 19: 379-80.
48. Storey JR, Calder CS, Potter DL. Role of topiramate for refractory migraine prophylaxis: a retrospective chart analysis.
49. Young WB, Hopkins MM, Shechter AL, Silberstein SD. Topiramate: a case series study in migraine prophylaxis. Cephalalgia 2002; 22: 659-63.
50. Edwards KR, Glantz MJ, Shea P, Norton JA, Cross N. A double-blind, randomized trial of topiramate versus placebo in the prophylactic treatment of migraine headache with and without aura. In XVIII Annual Scientific Meeting. Fort Lauderdale, FL: American Pain Society; 1999.
51. Potter DL, Hart DE, Calder CS, Story JR. A double-blind, randomized, placebo-controlled, parallel study to determine the efficacy of topiramate in the prophylactic treatment of migraine. Neurology 2000; 54 (Suppl 3): 15.
52. Hershey AD, Powers SW, Vockell AB, LeCates S, Kabbouche M. Effectiveness of topiramate in the prevention of childhood headaches. Headache 2002; 42: 810-8.
53. Sorge F, Barone P, Steardo L, Romano MR. Amitriptyline as a prophylactic for migraine in children. Acta Neurol 1982; 4: 362-7.
54. Hershey AD, Powers SW, Bentti AL, deGrauw TJ. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache 2000; 40: 53-49.
55. Elser JM, Woody RC. Migraine headache in the infant and young children. Headache 1990; 30: 366-8.
56. Lavenstein B. A comparative study of cyproheptadine, amitriptyline, and propranolol in the treatment of pre-adolescent migraine. Cephalalgia 1991; 11 (Suppl 11): 122-3.
57. Battistella PA, Ruffilli R, Cernetti R, Pettenazzo A, Baldin L, Bertoli S, et al. A placebo-controlled crossover trial using trazodone in pediatric migraine. Headache 1993; 33: 36-9.
58. Ludvgsson J. Propranolol used in the prophylaxis of migraine in children. Acta Neurol Scand 1974; 50: 109-15.
59. Forsythe WI, Gilles D, Sills MA. Propranolol ('Inderal') in the treatment of childhood migraine. Dev Med Child Neurol 1984; 26: 737-41.
60. Olness K, MacDonald JT, Uden DL. Comparison of self-hypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics 1987; 79: 593-7.
61. Lutschg J, Vassella F. The treatment of juvenile migraine using flunarizine or propranolol. Schweiz Med Wochenschr 1990; 120: 1731-6.
62. Evers S. Drug treatment of migraine in children. A comparative review. Paediatr Drugs 1999; 1: 7-19.
63. Noronha MJ. Double blind randomized cross-over trial of timolol in migraine prophylaxis of children. Cephalalgia 1985; 5 (Suppl 3): 174-5.
64. Sorge F, De Simone R, Marano E, Nolano M, Orefice G, Carrieri P. Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. Cephalalgia 1988; 8: 1-6.
65. Sorge F, Marano E. Flunarizine v placebo in childhood migraine. A double-blind study. Cephalalgia 1985; 5 (Suppl 2): 145-8.
66. Pothmann R. Calcium antagonist flunarizine vs low dose acetylsalicylic acid in childhood migraine: a double-blind study. Cephalalgia 1987; 7 (Suppl 6): 385-6.
67. Castellana M, Carini U, Capirei G. Calcium entry blockers in the treatment of primary headache in childhood: our experience with flunarizine and nimodipine. In Lanzi G, Balottin U, Cernibori A, eds. Headache in children and adolescents. Amsterdam: Elsevier; 1989. p. 349-52.
68. Migraine-Nimodipine European Study Group. European multicenter trial of nimodipine in the prophylaxis of common migraine (migraine without aura). Headache 1989; 29: 633-8.
69. Migraine-Nimodipine European Study Group. European multicenter trial of nimodipine in the prophylaxis of classic migraine (migraine with aura). Headache 1989; 29: 639-42.
70. Battistella PA, Ruffilli R, Moro R, Fabiani N, Bertoli S, Antolini A, et al. A placebo-controlled crossover trial of nimodipine in pediatric migraine. Headache 1990; 30: 264-8.
71. Peroutka SJ, Allen GS. The calcium antagonist properties of cyproheptadine: implications for antimigraine action. Neurology 1984; 34: 304-9.
72. Bille B, Ludvingsson J, Sanner G. Prophylaxis of migraine in children. Headache 1977; 17: 61-3.
73. Salmon MA. Pizotifen (BC.105.Sandomigran) in the prophylaxis of childhood migraine [abstract]. Cephalalgia 1985; 5 (Suppl 3): 178.
74. Gilles D, Sills M, Forsythe I. Pizotifen (Sandomigran) in childhood migraine. Eur Neurol 1986; 25: 32-5.
75. Symon DNK, Russell G. The general paeditricians view of migraine: a review of 250 cases. In Lanzi G, Balottin U, Cernibori A, eds. Headache in children and adolescents. Amsterdam: Elsevier; 1989. p. 61-6.
76. Burgio R, Borgatti R, Scarabello E. The pharmacologic treatment of migraine with tryptophan and pizotifen. In Lanzi G, Balottin U, Cernibori A, eds. Headache in children and adolescents. Amsterdam: Elsevier; 1989: 339-47.
77. Del Bene E, Poggioni M, Michelacci S. Lisuride as a migraine prophylactic in children: an open clinical trial. Int J Clin Pharmacol Res 1983; 3: 137-41.
78. Supplementation with omega-3 polyunsaturated fatty acids in management of recurrent migraine in adolescents. J Adolesc Health 2002; 31: 154-61.
79. Sillanpää M, Koponen M. Papaverine in the prophylaxis of migraine and other vascular headaches in children. Acta Paediatr Scand 1978; 67: 209-12.
80. Sillanpää M. Clonidine prophylaxis of childhood migraine and other vascular headaches. Headache 1977; 17: 28-31.
81. Sills M, Congdon P, Forsythe I. Clonidine and childhood migraine: a pilot and double-blind study. Dev Med Child Neurol 1982; 24: 837-41.
82. Santucci M, Cortelli P, Rossi PG, Baruzzi A, Sacqueqna T. L-5-Hydroxytryptophan versus placebo in childhood migraine prophylaxis: a double-blind crossover study. Cephalalgia 1986; 6: 155-7.
83. Pothmann R, Winter K. Migraine prophylaxis with DHE: a double-blind placebo-controlled study. Cephalalgia 1989; 9 (Suppl 10): 427-8.